Literature DB >> 27870295

Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix.

Louise De Brot1, Bruno Pellegrini1, Sabrina Teixeira Moretti1, Dirce Maria Carraro1, Fernando Augusto Soares1, Rafael Malagoli Rocha1, Glauco Baiocchi2, Isabela Werneck da Cunha1, Victor Piana de Andrade1.   

Abstract

BACKGROUND: Infections with multiple human papillomavirus (HPV) types (mHPV) in Papanicolaou tests have been reported but the histologic correlation and clinical meaning remains debatable.
METHODS: The authors prospectively tested 37 HPV types using the Linear Array HPV Genotyping Test and correlated the results to cytology and histology findings in 260 women evaluated from June 2009 to October 2011 and followed for up to 60 months.
RESULTS: HPV was detected in 148 of 235 samples (63%) and high-risk HPV was detected in 132 samples (56%). mHPV infection was found to be twice as common as single HPV (sHPV) infection and was detected more frequently in low-grade squamous intraepithelial lesion (LSIL) (48 of 83 samples [58%]) and high-grade squamous intraepithelial lesion or invasive carcinoma (HSIL + (26 of 47 samples [55%]) compared with other categories (P<.001). Of 34 LSIL/cervical intraepithelial neoplasia 1 (CIN1) index cases, 13 of 21 patients with mHPV (61.9%) persisted on CIN1, whereas no histologic abnormality was detected during follow-up in all 12 patients with sHPV infection (high risk or low risk) (P<.001). Eighteen of 20 patients with HSIL/cervical intraepithelial neoplasia 2 (CIN2) (90%) and high-risk mHPV persisted on HSIL+/CIN2 + whereas 6 of 11 patients with sHPV infection did not demonstrate HSIL+/CIN2 + on follow-up (54.5%) (P = .066). Approximately 40% of women with HSIL were infected by high-risk HPV types other than types 16 or 18.
CONCLUSIONS: High-risk mHPV infection identified patients with persistent LSIL/CIN1 and may to help identify patients at higher risk of disease progression to HSIL+/CIN2+. Longer follow-up will clarify the role of mHPV testing in patient care. Cancer Cytopathol 2017;125:138-143.
© 2016 American Cancer Society. © 2016 American Cancer Society.

Entities:  

Keywords:  cervical cancer; coinfection; gynecological cytology; human papillomavirus; human papillomavirus genotyping; intraepithelial lesions

Mesh:

Year:  2016        PMID: 27870295     DOI: 10.1002/cncy.21789

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  9 in total

1.  High Prevalence of Non-Vaccinated Oncogenic Human Papillomavirus Genotypes in High-Grade Squamous Intraepithelial Lesions of the Cervix: Thought-Provoking Results of a Detailed HPV Genotype Analysis.

Authors:  Orsolya Rideg; Tímea Dergez; Kornélia Farkas; Krisztina Kovács; Endre Kálmán; Tamás Tornóczky; Angéla Oszter
Journal:  Vaccines (Basel)       Date:  2022-05-10

2.  Prevalence and Distribution of Human Papillomavirus Genotypes (1997-2019) and Their Association With Cervical Cancer and Precursor Lesions in Women From Southern Mexico.

Authors:  Luz Del Carmen Alarcón-Romero; Jorge Organista-Nava; Yazmín Gómez-Gómez; Julio Ortiz-Ortiz; Daniel Hernández-Sotelo; Oscar Del Moral-Hernández; Miguel Angel Mendoza-Catalán; Ramón Antaño-Arias; Marco Antonio Leyva-Vázquez; Natividad Sales-Linares; Verónica Antonio-Véjar; Berenice Illades-Aguiar
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

3.  Increased HPV L1 gene methylation and multiple infection status lead to the difference of cervical epithelial cell lesion in different ethnic women of Xinjiang, China.

Authors:  Feng Yang-Chun; Zhang Yuan; Liu Cheng-Ming; Huang Yan-Chun; Ma Xiu-Min
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  HPV-based screening for cervical cancer among women 55-59 years of age.

Authors:  Lovisa Bergengren; Gabriella Lillsunde-Larsson; Gisela Helenius; Mats G Karlsson
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

5.  Association between HPV infection and prostate cancer in a Mexican population.

Authors:  Olivia Medel-Flores; Vania Alejandra Valenzuela-Rodríguez; Rodolfo Ocadiz-Delgado; Leonardo Josué Castro-Muñoz; Sandra Hernández-Leyva; Gabriel Lara-Hernández; Jesús-Gabriel Silva-Escobedo; Patricio Gariglio Vidal; Virginia Sánchez-Monroy
Journal:  Genet Mol Biol       Date:  2018-11-29       Impact factor: 1.771

6.  Human Papillomavirus Coinfection in the Cervical Intraepithelial Lesions and Cancer of Mexican Patients.

Authors:  Juan Ramón Padilla-Mendoza; Lucía Angélica Gómez-López; Mavil López-Casamichana; Elisa Irene Azuara-Liceaga; Enoc Mariano Cortés-Malagón; Lilia López-Cánovas; Octavio Daniel Reyes-Hernández; Mario Alberto Rodríguez; José Bonilla-Delgado; Israel López-Reyes
Journal:  Biomed Res Int       Date:  2020-11-13       Impact factor: 3.411

7.  Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection.

Authors:  Jinhee Kim; Moonsik Kim; Ji Young Park
Journal:  J Pathol Transl Med       Date:  2022-09-13

8.  Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women.

Authors:  Mariel A Oyervides-Muñoz; Antonio A Pérez-Maya; Celia N Sánchez-Domínguez; Anais Berlanga-Garza; Mauro Antonio-Macedo; Lezmes D Valdéz-Chapa; Ricardo M Cerda-Flores; Victor Trevino; Hugo A Barrera-Saldaña; María L Garza-Rodríguez
Journal:  Viruses       Date:  2020-03-31       Impact factor: 5.048

9.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.